Cargando…

The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression

Enhanced nucleoside metabolism is one of the hallmarks of cancer. Uridine-cytidine kinase 2 (UCK2) is a rate-limiting enzyme of the pyrimidine salvage synthesis pathway to phosphorylate uridine and cytidine to uridine monophosphate (UMP) and cytidine monophosphate (CMP), respectively. Recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yi, Wei, Xin-dong, Guo, Luoting, Wu, Kai, Le, Jiamei, Ma, Yujie, Kong, Xiaoni, Tong, Ying, Wu, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163393/ https://www.ncbi.nlm.nih.gov/pubmed/35669416 http://dx.doi.org/10.3389/fonc.2022.904887

Ejemplares similares

Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma
por: Cai, Jie, et al.
Publicado: (2020)

Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles
por: Aishanjiang, Kedeerya, et al.
Publicado: (2021)

Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p/UCK2
por: Zhang, Qiangnu, et al.
Publicado: (2020)

Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance
por: Zhou, Junying, et al.
Publicado: (2022)

Proline Metabolism in Tumor Growth and Metastatic Progression
por: D'Aniello, Cristina, et al.
Publicado: (2020)

Bioenergetic and Metabolic Adaptation in Tumor Progression and Metastasis
por: Herst, Patries M., et al.
Publicado: (2022)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism
por: Penet, Marie-France, et al.
Publicado: (2016)

A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment
por: Liu, Xu, et al.
Publicado: (2022)

Does an Interdisciplinary Network Improve Dementia Care? Results from the IDemUck-Study
por: Köhler, Leonore, et al.
Publicado: (2014)

Uridine‐cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer
por: Wu, Yingjie, et al.
Publicado: (2019)

Pharmacology, Toxicology, and Metabolism of Sennoside A, A Medicinal Plant-Derived Natural Compound
por: Le, Jiamei, et al.
Publicado: (2021)

Emerging Landscapes of Tumor Immunity and Metabolism
por: Wu, Fan, et al.
Publicado: (2020)

MicroRNAs Regulate Metabolic Phenotypes During Multicellular Tumor Spheroids Progression
por: Muciño-Olmos, Erick Andrés, et al.
Publicado: (2020)

An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma
por: Guo, Han, et al.
Publicado: (2022)

Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy
por: Cai, Limeng, et al.
Publicado: (2021)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Amino acid metabolic reprogramming in tumor metastatic colonization
por: Wang, Zihao, et al.
Publicado: (2023)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
por: Wu, Shaojie, et al.
Publicado: (2021)

PPA1, an energy metabolism initiator, plays an important role in the progression of malignant tumors
por: Wang, Shuying, et al.
Publicado: (2022)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment
por: Lin, Xiaoping, et al.
Publicado: (2020)

The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
por: Li, Ying, et al.
Publicado: (2021)

Boosting the photocatalytic performance of Cu(2)O for hydrogen generation by Au nanostructures and rGO nanosheets
por: Ma, Yujie, et al.
Publicado: (2022)

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance
por: Thakur, Abhimanyu, et al.
Publicado: (2023)

Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming
por: Nickerson, Jeffrey A., et al.
Publicado: (2017)

SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma
por: Kong, Weiyu, et al.
Publicado: (2022)

Editorial: Cancer Cell Metabolism and Immunomodulation in the Context of Tumor Metastasis
por: Dong, Qiongzhu, et al.
Publicado: (2022)

P1301: BIOLOGICAL SIGNIFICANCE OF UCK2 IN HTLV-1-INFECTED CELLS IN ATL LEUKEMOGENESIS AND ACQUIRED RESISTANCE TO AZACITIDINE
por: Watanabe, T., et al.
Publicado: (2022)

Metabolic Plasticity of Tumor Cell Mitochondria
por: Cannino, Giuseppe, et al.
Publicado: (2018)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

Metabolism in the progression and metastasis of brain tumors
por: Tyagi, Abhishek, et al.
Publicado: (2022)

LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells
por: Lu, Wei, et al.
Publicado: (2019)

The Role of Lipid Metabolism in Gastric Cancer
por: Cui, Meng-Ying, et al.
Publicado: (2022)

CircRNA-UCK2 Increased TET1 Inhibits Proliferation and Invasion of Prostate Cancer Cells Via Sponge MiRNA-767-5p
por: Xiang, Zhendong, et al.
Publicado: (2019)

RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma
por: Xiao, Dongdong, et al.
Publicado: (2022)

Potential of Induced Metabolic Bioluminescence Imaging to Uncover Metabolic Effects of Antiangiogenic Therapy in Tumors
por: Indraccolo, Stefano, et al.
Publicado: (2016)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

METTL3-induced UCK2 m(6)A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway
por: Wu, Hao, et al.
Publicado: (2021)

Glucose Metabolism Reprogramming of Primary Tumor and the Liver Is Associated With Disease-Free Survival in Patients With Early NSCLC
por: Tan, Hongpei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_skb3bb5d4u9n8fg42ahs44671m